{"id":44,"date":"2025-05-23T17:31:05","date_gmt":"2025-05-23T08:31:05","guid":{"rendered":"https:\/\/www.ccpid.nagasaki-u.ac.jp\/english\/?page_id=44"},"modified":"2026-04-01T08:39:53","modified_gmt":"2026-03-31T23:39:53","slug":"about","status":"publish","type":"page","link":"https:\/\/www.ccpid.nagasaki-u.ac.jp\/english\/about\/","title":{"rendered":"What is the CCPID"},"content":{"rendered":"
<\/a>\u3000<\/pre>\n
What is the National Research Center for the Control and Prevention of Infectious Diseases(CCPID), Nagasaki University<\/strong><\/h3>\n\n\n\n\n\n
\n
Mission Statement<\/h6>\n
\u3000Infectious diseases pose a serious threat not only to human life and health but also to the stability of economic and social systems.
The National Research Center for the Control and Prevention of Infectious Diseases at Nagasaki University is committed to overcoming infectious diseases caused by highly pathogenic viruses and emerging\/re-emerging infectious diseases.
Through collaboration with domestic and international research institutions and experts, and by leveraging the Center\u2019s affiliated BSL-4 facility and overseas research stations, in pursuit of constructive engagement with the local community, the Center has the mission of achieving the following objectives:

\u30fb Elucidating viral replication mechanisms and disease pathogenesis
\u30fb Developing diagnostic, preventive, and therapeutic methods
\u30fb Investigating the global ecology of viruses
\u30fb Building the capacity of researchers to lead global infectious disease research
\u30fb Fostering highly skilled specialists with advanced knowledge, technical expertise, and strong safety awareness
<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n
 <\/p>\n\n\n
The Center has its origins in the research base for infectious disease, which was established in 2017, and when it became an independent department as a University Research Institute of Nagasaki University in April 2022, it was renamed the \u201cNational Research Center for the Control and Prevention of Infectious Diseases(CCPID)\u201d. It has also been certified by the Ministry of Education, Culture, Sports, Science and Technology(MEXT) as a \u201cResearch Center for emerging infectious diseases\u201d for joint usage \/ research by related researchers nationwide.<\/p>\n
We will promote collaboration with research institutions in other countries that have BSL-4 facilities, and support research activities using BSL-4 facilities by related researchers throughout Japan.<\/p>\n
CCPID Brochure(PDF)<\/a><\/strong><\/p>\n\n\n
\n
\n
\n
\n
\"\"<\/a>
The external appearance of CCPID (The building in the foreground is the main building, and the building in the background is the BSL-4 facility)<\/figcaption><\/figure>\n<\/div>\n\n\n\n
\n
\"\"<\/a>
The introspection of the BSL-4 laboratory, CCPID<\/figcaption><\/figure>\n<\/div>\n<\/div>\n\n\n\n
The above two photos can only be used for the purpose of introducing the university's BSL-4 facility.
When using them, please refrain from cropping or altering the photos.<\/p>\n\n\n\n
**********<\/p>\n\n\n\n
\n
\n
\"\"<\/a>
Image video of the BSL-4 laboratory, CCPID (0:31)<\/a><\/figcaption><\/figure>\n<\/div>\n\n\n\n
\n
\"\"<\/a>
Image video of the laboratory (BSL-2) in the main building of CCPID (0:24)<\/a><\/figcaption><\/figure>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n
Note : The narration for these videos was created using \u201condoku3.com\u201d.\u3000<\/p>\n
<\/a>\u3000<\/pre>\n
Message from the Dean<\/h3>\n\n\n\n
\n
\"\"<\/p>\n
Introduction video by Dean, Hiroyuki Moriuchi <\/a><\/p>\n<\/td>\n
\n
Infectious diseases that occur overseas are not something we can afford to ignore. Smallpox was brought back to Japan by a group of envoys in 735 and caused a major epidemic that killed around 30% of the population at the time. Under the National Isolation policy between 1639 and 1854, the number of infectious diseases brought into Japan from overseas decreased. Still, the disease, supposed to be influenza that landed on the artificial island of Dejima, took three years to reach Edo, the capital of Japan. Then, it killed 80,000 people there in a single month. Syphilis, a once endemic disease in the New World, arrived in Japan just 18 years after Columbus and his crew brought it back to Europe, and it became a national disease during the Edo period. Considering the transportation conditions at the time, that was an astonishingly fast speed. The dreaded smallpox was eradicated through vaccination, and syphilis became a disease that could be easily treated with penicillin. Vaccines and antivirals also prevent influenza from becoming serious. All of these are monumental achievements of medical research.<\/p>\n
When SARS broke out, Japan was unaffected, and many Japanese people felt that \u201cno matter what happens overseas, Japan will be fine.\u201d However, COVID-19, which is caused by a closely related coronavirus, quickly spread around the world, including Japan, and caused many victims. Not long before that, MERS, a disease similar to SARS, was thought to be an endemic disease of the Middle East; however, many people got infected with and died from it in neighboring South Korea, causing a big commotion.<\/p>\n
In recent years, humans have encountered new pathogens much more frequently due to environmental destruction and climate change. Since people and goods are moving around the world at speeds that would have been unimaginable in the past, there is always a risk that an emerging infectious disease that has broken out somewhere in the world could enter Japan without us even knowing. Border measures are ineffective against infectious diseases that have long incubation periods or are transmitted from asymptomatic carriers. Moreover, we cannot stop a highly pathogenic avian influenza or West Nile fever at immigration since migratory birds carry them in.<\/p>\n
\u00a0Most people probably think that the Ebola virus disease is endemic in Africa. However, the epidemic in West Africa in 2014-2016 spread to European and US countries. The belief that it will never enter Japan is a completely unfounded delusion.
\u00a0In addition to Ebola virus disease, there is an urgent need to develop effective therapeutic and preventive measures for diseases such as Lassa fever, Crimean-Congo hemorrhagic fever, and henipavirus infections, as these diseases have high fatality rates. Naturally, it is essential to have an experimental facility with the highest safety features to advance research on these pathogens, and that is a biosafety level 4 facility (BSL-4 facility).<\/p>\n
There are currently more than 60 BSL-4 facilities in over 20 countries worldwide. In Japan, the only BSL-4 facility is the one at the Japan Institute for Health Security(JIHS), which was built about 40 years ago and is only permitted to conduct experimental work that leads to diagnosis and treatment in response to an emergency. However, just as the development of smallpox vaccines, penicillin, and COVID-19 vaccines has saved many lives, it is extremely important to advance basic medical research on BSL-4 pathogens. A BSL-4 research facility with cutting-edge equipment has been needed in Japan to protect the Japanese people and contribute to the world.<\/p>\n
In this context, Nagasaki University sent out a message from the President in 2010 announcing that it would begin considering establishing a BSL-4 facility, and the Ministerial Meeting of the Government decided to provide support in 2016. Accordingly, the research institution that would become the forerunner to the National Research Center for the Control and Prevention of Infectious Diseases (CCPID) was established, and the BSL-4 facility was constructed in July 2021. In April 2022, CCPID was reborn as the University Research Institute and certified by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) as a Joint Usage\/Research Center for related researchers nationwide. In January 2025, we received designation as a \u201cFacility for Possessing Specified Class I Pathogens, etc. \u201d from the Minister of Health, Labour and Welfare. Currently, we are preparing for full-scale operation using BSL-4 pathogens by verifying the functions and safety of the facility and providing the necessary training.<\/p>\n
At this center, we will promote infectious disease research using BSL-4 facilities through collaboration between researchers from Nagasaki University and other institutions across Japan. At the same time, we will also train researchers who can safely handle BSL-4 pathogens and experts in biosafety management. Nagasaki has contributed to the advancement of medicine as the birthplace of Western medicine. Smallpox vaccination also spread from Nagasaki to the rest of Japan, saving many lives. Now, Nagasaki is aiming to contribute to medical research across Japan and around the world.
To achieve this, I believe that the most important thing is to operate the BSL-4 facility absolutely safely, build a relationship of trust with the people in the community, and have them watch over our research activities with peace of mind. I sincerely ask for your understanding, cooperation, and support.<\/p>\n
\u00a0November 2025<\/p>\n
Hiroyuki Moriuchi, MD, PhD
Dean, the National Research Center for the Control and Prevention of Infectious Diseases(CCPID), Nagasaki University\u3000<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n
<\/a>\u3000<\/pre>\n
Organization<\/h3>\n\n\n
\"\"<\/figure>\n\n\n\n
\n
\n
Click here to go to the home page.\u2193<\/p>\n\n\n\n
\n
\n
\n
\n
Emerging Infectious Diseases<\/a><\/p>\n<\/div>\n\n\n\n
\n
Viral Ecology<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n
Virus Infection Dynamics<\/a><\/p>\n<\/div>\n\n\n\n
\n
Immune Dynamics in Viral Infections<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n
\n
Medical and Applied Virology<\/a><\/a><\/p>\n<\/div>\n\n\n\n
\n
Molecular Pathogenesis of Viral Infections<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n
Virus-Host Interaction<\/a><\/p>\n<\/div>\n\n\n\n
<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n
<\/a>*********<\/p>\n\n\n
History<\/h3>\n\n\n\n
 <\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
2006-2008<\/td>\n\u201cResearch and Study on Countermeasures for Emerging Infectious Diseases that Require Advanced Safety Laboratories (BSL-4) Facilities\u201d was conducted with Special Coordination Funds for Promoting Science and Technology<\/td>\n<\/tr>\n
May 2010<\/td>\nThe president's message announced that Nagasaki University would begin considering the establishment of a BSL-4 facility.<\/td>\n<\/tr>\n
June 2015<\/td>\nNagasaki Prefecture, Nagasaki City, and Nagasaki University concluded a basic agreement on the establishment of a research base for infectious diseases.<\/td>\n<\/tr>\n
November 2016<\/td>\nThe 14 economic or medical organizations submitted a request on a BSL-4 facility to Nagasaki Prefecture and Nagasaki City.<\/td>\n<\/tr>\n
November 2016<\/td>\nAt a Ministerial Meeting, it was decided to proceed with the plan to establish a BSL-4 facility at Nagasaki University as a national policy, and to provide support for Nagasaki University as \u201cthe government\u2019s involvement\u201d.  <\/td>\n<\/tr>\n
November 2016<\/td>\nThe governor of Nagasaki Prefecture and the mayor of Nagasaki City agreed to cooperate in the realization of the Nagasaki University's facility development plan.<\/td>\n<\/tr>\n
September 2017<\/td>\n\u201cBasic Concept for a Highly Safe Laboratory (BSL-4) Facility to be the Core of the Research Base for Infectious Diseases in Nagasaki University was formulated and published.<\/td>\n<\/tr>\n
January 2019<\/td>\nConstruction of the BSL-4 facility (laboratory building) began<\/td>\n<\/tr>\n
July 2021<\/td>\nCompletion of BSL-4 facility (laboratory building)<\/td>\n<\/tr>\n
March 2022<\/td>\nCompletion of the main building of the National Research Center for the Control and Prevention of Infectious Diseases(CCPID)<\/td>\n<\/tr>\n
April 2022<\/td>\nThe National Research Center for the Control and Prevention of Infectious Diseases (CCPID) as a University Research Institute was established.<\/td>\n<\/tr>\n
April 2022<\/td>\nCertified as the Joint Usage \/ Research Center for emerging infectious diseases\uff08April 2022-March 2028\uff09 by the Ministry of Education, Culture, Sports, Science and Technology (MEXT)<\/td>\n<\/tr>\n
October 2022<\/td>\n One of the synergy centers (planned for FY2022-FY2026)for the \u201cStrategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response (SCARDA)\u201d the project of the Japan Agency for Medical Research and Development (AMED) has been established in DEJIMA Infectious Disease Research Alliance, which CCPID is a part  of.<\/td>\n<\/tr>\n
January 2025<\/td>\nThe BSL-4 facility was designated by the Minister of Health, Labor and Welfare as a Facility for Possessing Specified Class I Pathogens, etc., based on the Act on the Prevention of Infectious Diseases and Medical Care for Patients with Infectious Diseases (the Infectious Diseases Control Law).<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n
\n
\u00a0<\/div>\n<\/div>\n\n\n\n
\n
<\/div>\n\n\n\n
<\/div>\n<\/div>\n\n\n\n
<\/p>\n","protected":false},"excerpt":{"rendered":"
\u3000 What is the National Research Center for the Control and Prevention of Infectious Diseases(CCPID), Nagasaki University Mission Statement \u3000Infectious diseases pose a serious threat not only to human life and health but also to the stability of economic and social systems.The National Research Center for the Control and Prevention of Infectious Diseases at Nagasaki […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":10,"comment_status":"closed","ping_status":"closed","template":"","meta":{"vkexunit_cta_each_option":"","footnotes":""},"class_list":["post-44","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.ccpid.nagasaki-u.ac.jp\/english\/wp-json\/wp\/v2\/pages\/44","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ccpid.nagasaki-u.ac.jp\/english\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ccpid.nagasaki-u.ac.jp\/english\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ccpid.nagasaki-u.ac.jp\/english\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ccpid.nagasaki-u.ac.jp\/english\/wp-json\/wp\/v2\/comments?post=44"}],"version-history":[{"count":20,"href":"https:\/\/www.ccpid.nagasaki-u.ac.jp\/english\/wp-json\/wp\/v2\/pages\/44\/revisions"}],"predecessor-version":[{"id":234,"href":"https:\/\/www.ccpid.nagasaki-u.ac.jp\/english\/wp-json\/wp\/v2\/pages\/44\/revisions\/234"}],"wp:attachment":[{"href":"https:\/\/www.ccpid.nagasaki-u.ac.jp\/english\/wp-json\/wp\/v2\/media?parent=44"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}